SAJE Pharma
SAJE Pharma
  • Home
  • About Us
  • What's New
  • Science
  • Development
  • Safety
  • Intellectual Property
  • Pipeline & Status
  • Collaborators & Advisors
  • Publications
  • More
    • Home
    • About Us
    • What's New
    • Science
    • Development
    • Safety
    • Intellectual Property
    • Pipeline & Status
    • Collaborators & Advisors
    • Publications
  • Home
  • About Us
  • What's New
  • Science
  • Development
  • Safety
  • Intellectual Property
  • Pipeline & Status
  • Collaborators & Advisors
  • Publications

One Pharmaceutical Target, Many Therapeutic Benefits

One Pharmaceutical Target, Many Therapeutic Benefits One Pharmaceutical Target, Many Therapeutic Benefits One Pharmaceutical Target, Many Therapeutic Benefits
Contact Us

One Pharmaceutical Target, Many Therapeutic Benefits

One Pharmaceutical Target, Many Therapeutic Benefits One Pharmaceutical Target, Many Therapeutic Benefits One Pharmaceutical Target, Many Therapeutic Benefits
Contact Us

What's New at SAJE this Year

New Therapeutic Activities

New Therapeutic Activities

New Therapeutic Activities

Identified 56 therapeutic activities of GSNO and GSNORis, including SPL-850 in ocular, autoimmune, neurodegenerative,

cardiovascular, respiratory, and metabolic disease.

Read More

Patent Fillings

New Therapeutic Activities

New Therapeutic Activities

Filed wide international patent rights for SPL-850 and related

molecules, claiming composition of matter in autoimmune, ocular, cardiovascular, and fibrotic diseases. 

Read More

Safety & PK

New Therapeutic Activities

Safety & PK

Clean safety data for SPL-850. Novel PK/PD for SPL-850 and active routes of administration: oral, topical, intravitreal, IP, IV.

Read More

SAJE Team Members

Matt Bradley

Matthews O. Bradley, Ph.D.

Matthews O. Bradley, Ph.D.

Matthews O. Bradley, Ph.D.

Founder, Chairman, President, and Chief Technical Officer


 mbradley@sajepharma.com

Read more
Helen Pentikis

Helen S Pentikis, Ph.D.

Matthews O. Bradley, Ph.D.

Matthews O. Bradley, Ph.D.

Founder, Chief Executive Officer, and Chief Scientific Officer


hpentikis@sajepharma.com

Read More
Richard Pariza

Richard J. Pariza, Ph.D.

Matthews O. Bradley, Ph.D.

Richard J. Pariza, Ph.D.

Senior Vice President, Chemistry


rpariza@sajepharma.com

Read More

Contact Us

Send Message

Have Questions?

Please reach out to us with any questions, inquiries, or requests for more information. 

SAJE Pharma

164 Saddleback Trl, Kalispell, Montana 59901, United States

office: 406-756-0240 cell: 301-332-0942 email: mbradley@sajepharma.com

Copyright © 2020 SAJE Pharma - All Rights Reserved.

  • Contact Us